share_log

德琪醫藥-B:自願公告 CD73小分子抑制劑ATG-037用於治療局部晚期及轉移性實體瘤的I期臨床試驗申請在中國獲批

ANTENGENE-B: VOLUNTARY ANNOUNCEMENT IND APPROVAL FOR THE PHASE I STAMINA-001 STUDY TO EVALUATE ATG-037 (CD73 INHIBITOR) FOR THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC SOLID TUMORS IN CHINA

Nov 2, 2022 08:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more